CompuGroup Medical SE & Co KgaA
XETRA:COP
Intrinsic Value
CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. [ Read More ]
The intrinsic value of one
COP
stock under the Base Case scenario is
58.13
EUR.
Compared to the current market price of 29.3 EUR,
CompuGroup Medical SE & Co KgaA
is
Undervalued by 50%.
CompuGroup Medical SE & Co KgaA's market capitalization is 1.5B EUR.
COP stock price is 29.3 EUR.
COP stock price (29.3 EUR) is 50% less than its Intrinsic Value (58.13 EUR).
COP has upside potential of 63% compared to the average analyst price target.
Open Wall St Estimates
COP has positive Operating Income for the last twelve months.
COP's Revenue has grown by 5% over the past 12 months.
COP's short-term assets (370m EUR) exceed its short-term liabilties (345m EUR).
COP's ROIC (Return on Invested Capital) has decreased in the last 3 years from 6% to 4%.
COP's D/E (Debt to Equity) is equal to 1.11.
COP's ROE (Return on Equity) for the past 12 months is positive and is equal to 7%.
COP's Revenue is forecast to grow at a rate of 5% per year over the next 3 years.
COP has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
COP has positive Net Income for the last twelve months.
COP's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
COP's Altman Z-Score is equal to 2.29.
COP's ROE (Return on Equity) has decreased in the last 3 years from 16% to 7%.
COP's Revenue has been growing by 12% per year for the last 3 years.
COP has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
COP's long-term assets (2B EUR) exceed its long-term liabilties (1B EUR).
COP has positive Free Cash Flow for the last twelve months.
COP has positive Gross Profit for the last twelve months.
COP has positive Net Debt. This means that the company has more debt (741m EUR) than cash and short-term investments (72m EUR).
COP generates enough operating income (112m EUR) to cover interest payments on its debt (27m EUR).
Valuation Backtest
CompuGroup Medical SE & Co KgaA
Run backtest to discover the historical profit from buying and selling
COP
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
CompuGroup Medical SE & Co KgaA
Balance Sheet Decomposition
CompuGroup Medical SE & Co KgaA
| Current Assets | 369.8m |
| Cash & Short-Term Investments | 72.3m |
| Receivables | 248.8m |
| Other Current Assets | 48.7m |
| Non-Current Assets | 1.5B |
| Long-Term Investments | 19.2m |
| PP&E | 165.7m |
| Intangibles | 1.3B |
| Other Non-Current Assets | 35.4m |
| Current Liabilities | 345.3m |
| Accounts Payable | 93m |
| Other Current Liabilities | 252.3m |
| Non-Current Liabilities | 887m |
| Long-Term Debt | 741.1m |
| Other Non-Current Liabilities | 145.9m |
Earnings Waterfall
CompuGroup Medical SE & Co KgaA
|
Revenue
|
1.2B
EUR
|
|
Cost of Revenue
|
-773m
EUR
|
|
Gross Profit
|
414.6m
EUR
|
|
Operating Expenses
|
-302.9m
EUR
|
|
Operating Income
|
111.8m
EUR
|
|
Other Expenses
|
-65.8m
EUR
|
|
Net Income
|
45.9m
EUR
|
Free Cash Flow Analysis
CompuGroup Medical SE & Co KgaA
COP Profitability Score
Profitability Due Diligence
CompuGroup Medical SE & Co KgaA's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
CompuGroup Medical SE & Co KgaA's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
COP Solvency Score
Solvency Due Diligence
CompuGroup Medical SE & Co KgaA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
CompuGroup Medical SE & Co KgaA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COP Price Targets Summary
CompuGroup Medical SE & Co KgaA
According to Wall Street analysts, the average 1-year price target for
COP
is 47.8 EUR
with a low forecast of 36.36 EUR and a high forecast of 73.5 EUR.
Shareholder Return
COP Price
CompuGroup Medical SE & Co KgaA
| Average Annual Return | -4.38% |
| Standard Deviation of Annual Returns | 32.63% |
| Max Drawdown | -67% |
| Market Capitalization | 1.5B EUR |
| Shares Outstanding | 52 239 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
CompuGroup Medical SE & Co KgaA
Country
Industry
Market Cap
Dividend Yield
Description
CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. The company is headquartered in Koblenz, Rheinland-Pfalz and currently employs 9,118 full-time employees. The company went IPO on 2007-05-04. The firm focuses on providing software solutions to healthcare institutions. The activities are divided into six segments: Ambulatory Software Services (AIS), providing practice management software and medical records; Pharmacy Information Systems (PCS), including integrated clinical, administrative and financial software applications for pharmacies; Hospital Information Systems (HIS), such as laboratory and special care information systems; Communication & Data (C&D), offering software interfaces for pharmaceutical and medical equipment manufacturers; provides Picture Archiving and Communication Systems (PACS); Workflow & Decision Support (WDS), delivering software for management support aimed at healthcare payers, such as health insurers and managed care companies, and Internet Service Provider (ISP), providing Internet for healthcare providers.
Contact
IPO
Employees
Officers
The intrinsic value of one
COP
stock under the Base Case scenario is
58.13
EUR.
Compared to the current market price of 29.3 EUR,
CompuGroup Medical SE & Co KgaA
is
Undervalued by 50%.
You don't have any saved screeners yet
